
CCRN Stock Forecast & Price Target
CCRN Analyst Ratings
Bulls say
Cross Country Healthcare is a healthcare workforce solutions company with an AI-powered digital platform and advisory services that help healthcare systems manage their labor ecosystem. Despite a decline in Q1/26 revenue and factors impacting the broader healthcare staffing industry, Cross Country exceeded revenue expectations and reported a 2% sequential increase in revenue led by their Nurse and Allied Staffing segment. However, given their agreement to go private with Knox Lane and the stock price being close to the offer price, maintaining a MARKET PERFORM rating with a price target of $13.25 is recommended. Upside risks include investments in technology leading to margin expansion and potential for a higher bid to emerge, while downside risks include loss of significant MSP customers and impacts from regulations or decreases in patient occupancy. The acquisition deal also highlights the value and potential of Cross Country's AI-powered platform for a financial buyer like Knox Lane.
Bears say
Cross Country Healthcare is facing challenges in retaining clients and generating revenue due to the competitive nature of the healthcare staffing industry and decreased demand for their services during the pandemic. The company's financials have been impacted, with a decrease in revenue and earnings, and there is uncertainty surrounding their ability to recover and grow in the next few years despite their AI-powered digital platform and restructuring initiatives. The recent sale of the company to Knox Lane at a valuation that reflects their current struggles suggests a lack of confidence in their potential future performance.
This aggregate rating is based on analysts' research of Cross Country Healthcare and is not a guaranteed prediction by Public.com or investment advice.
CCRN Analyst Forecast & Price Prediction
Start investing in CCRN
Order type
Buy in
Order amount
Est. shares
0 shares